or
forgot password
  • cancer clinical trials in rockville centre, NY

  • Comparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's Lymphoma
    South Shore Hematology-Oncology Associates
    Rockville Centre, New York 11570
    Lymphoma, Follicular, Lymphoma, Mixed-Cell, Follicular, Lymphoma, Small Cleaved-Cell, Follicular, Lymphoma, Low-Grade
    Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma
    Memorial Sloan-Kettering Cancer Center at Mercy Medical Center
    Rockville Centre, New York 11570
    Stomach Neoplasms, Esophageal Neoplasms
    Study of Biweekly Capecitabine Dosing With Bevacizumab for the Treatment of Metastatic Breast Cancer Based Upon the Norton-Simon Mathematical Model
    Memorial Sloan-Kettering Cancer Center at Mercy Medical Center
    Rockville Centre, New York 11570
    Breast Cancer
    Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma
    Memorial Sloan-Kettering Cancer Center at Mercy Medical Center
    Rockville Centre, New York 11570
    Myeloproliferative Disorder, Urothelial Carcinoma, Cancer
    Clinical and Translational Study of MK-0646 in Patients With Metastatic Neuroendocrine Tumors (NET)
    Memorial Sloan-Kettering Cancer Center at Mercy Medical Center
    Rockville Centre, New York 11570
    Neuroendocrine Tumors, Metastatic Neuroendocrine Tumors
    Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer
    Memorial Sloan-Kettering Cancer Center at Mercy
    Rockville Centre, New York 11570
    Breast Cancer
    Cetuximab at Either 500 or 750 mg/m2 Every Other Week for Recurrent or Metastatic Head and Neck Squamous Cell Cancer
    Memorial Sloan-Kettering at Mercy Medical Center
    Rockville Centre, New York
    Head and Neck, Squamous Cell Cancer
    Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity - Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck Cancer
    Memorial Sloan-Kettering Cancer Center at Mercy Medical Center
    Rockville Centre, New York 11570
    Head and Neck Cancer
    Cetuximab in Patients With Lung Adenocarcinoma Receiving Erlotinib That Have Developed "Acquired Resistance" to Erlotinib
    Memorial Sloan-Kettering Cancer Center at Mercy Medical Center
    Rockville Centre, New York 11570
    Lung Adenocarcinoma
    Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer
    Memorial Sloan-Kettering Cancer Center - Rockville Centre
    Rockville Centre, New York 11570
    Head and Neck Cancer
    Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer
    Memorial Sloan-Kettering Cancer Center at Mercy Medical Center
    Rockville Centre, New York 11570
    Lung Cancer
    Survey and Blood Sample Collection for Patients With Lung Cancer Who Never Smoked Cigarettes
    Memorial Sloan-Kettering Cancer Center at Mercy Medical Center
    Rockville Centre, New York 11570
    Lung Cancer
    Neoadjuvant FOLFOX Plus Bevacizumab Chemotherapy in Patients With Locally Advanced Colon Cancer
    Memorial Sloan-Kettering Cancer Center at Mercy Medical Center
    Rockville Centre, New York 11570
    Colon Cancer
    Gemcitabine, Cisplatin, and Sunitinib (GC-S) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer
    Memorial Sloan-Kettering Cancer Center at Mercy Medical Center
    Rockville Centre, New York 11570
    Bladder Cancer, Urinary Bladder